Synedgen Company
.jpg)
Synedgen develops novel therapies and products to reduce infection and inflammation of dermal, oral, mucosal, and ophthalmic surfaces.
Total Funding:
$15 890 877
Headquarters:
Claremont, California, United States
Funding Status:
undisclosed
Employee Number:
11-50
Estimated Revenue:
$1M to $10M
Investment Stage:
N/A
Last Funding Type:
Venture - Series Unknown
Number Of Exists:
N/A
Technology:
Preventive Medicine
Investor Type:
N/A
Last Funding Date:
2020-01-29
Founded Date:
2009-01-01
Industry:
PharmTech